Polyvinylamine with moderate binding affinity as a highly effective vehicle for RNA delivery
Ye Tian,Yipu Zhao,Chong Yin,Shenxing Tan,Xue Wang,Chaofei Yang,Tuo-Di Zhang,Xi Zhang,Fei Ye,Jing Xu,Xianglong Wu,Li Ding,Jie Zhang,Jiawei Pei,Xue-Ting Wang,Rui Xue Zhang,Jianrong Xu,Weisi Wang,Carlos D M Filipe,Todd Hoare,Da-Chuan Yin,Airong Qian,Xudong Deng,Carlos D.M. Filipe
DOI: https://doi.org/10.1016/j.jconrel.2022.03.003
IF: 11.467
2022-05-01
Journal of Controlled Release
Abstract:Polymeric carriers for RNA therapy offer potential advantages in terms of low immunogenicity, promoting modifiability and accelerating intracellular transport. However, balancing high transfection efficacy with low toxicity remains challenging with polymer-based vehicles; indeed, polyethyleneimine (PEI) remains the "gold standard" polymer for this purpose despite its significant toxicity limitations. Herein, we demonstrate the potential of polyvinylamine (PVAm), a commodity high-charge cationic polymer used in the papermaking industry and has similar structure with PEI, as an alternative carrier for RNA delivery. High levels of transfection of normal, tumor, and stem cells with a variety of RNA cargoes including small interfering RNA (siRNA), microRNA (miRNA), and recombinant RNA can be achieved in vitro under the proper complex conditions. While, both the anti-tumor effect achieved in a xenograft osteosarcoma model and lipid-lowering activity observed in a hyperlipidemia mice indicate the potential for highly effective in vivo activity. Of note, both the transfection efficiency and the cytotoxicity of PVAm compare more favorably with those of PEI, with PVAm offering the additional advantages of simpler purification and significantly lower cost. In addition, the mechanism for the difference in transfection efficiency between PVAm and PEI is explored by molecular docking as well as analyzing the process of association and dissociation between polymers (PVAm and PEI) and nucleic acids. Our research provides a novel, non-toxic, and cost-effective carrier candidate for next generation RNA therapy, and elucidates the potential mechanism of PVAm for its efficient delivery of RNA.
pharmacology & pharmacy,chemistry, multidisciplinary